Rosen's Breast Pathology, 4e

409

Ductal Carcinoma In Situ

with ductal carcinoma in situ of the breast. Breast Cancer Res Treat 2012;131:801–808. 325. Sänger N, Effenberger KE, Riethdorf S, et al. Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ . Int J Cancer 2011;129:2522–2526. 326. Pathology Working Group Breast Cancer Task Force. Standard- ized management of breast cancer specimens. Am J Clin Pathol 1973;60:789–798. 327. Goldstein NS, Lacerna M, Vicini F. Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast. Am J Clin Pathol 1998;110:357–367. 328. Hodi Z, Ellis IO, Elston CW, et al. Comparison of margin assessment by radial and shave sections in wide local excision specimens for inva- sive carcinoma of the breast. Histopathology 2010;56:573–580. 329. Caughran JL, Vicini FA, Kestin LL, et al. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy. Ann Surg Oncol 2009;16:3020–3027. 330. Guidroz JA, Larrieux G, Liao J, et al. Sampling of secondary margins decreases the need for re-excision after partial mastectomy. Surgery 2011;150:802–809. 331. Goldstein SN. Controversies in pathology in early-stage breast cancer. Semin Radiat Oncol 2011;21:20–25. 332. Melstrom LG, Melstrom KA, Wang EC, et al. Ductal carcinoma in situ : size and resection volume predict margin status. Am J Clin Oncol 2010;33:438–442. 333. Coopey S, Smith BL, Hanson S, et al. The safety of multiple re- excisions after lumpectomy for breast cancer. Ann Surg Oncol 2011;18:3797–3801. 334. Nayak A, Bhuiya TA. Utility of cytokeratin 5/6 and high-molecular- weight keratin in evaluation of cauterized surgical margins in ex- cised specimens of breast ductal carcinoma in situ . Ann Diagn Pathol 2011;15:243–249. 335. GoldhirschA, Ingle JN, Gelber RD, et al. Thresholds for therapies: high- lights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 2009;20:1319–1329. 336. Hughes LL, Wang M, Page DL, et al. Local excision alone without irra- diation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol 2009;27:5319–5324. 337. Vincens E, Alves K, Lauratet B, et al. Margin status in ductal carci- noma in situ of the breast (in French). Bull Cancer 2008;95:1155–1159. 338. Dunne C, Burke JP, Morrow M, et al. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ . J Clin Oncol 2009;27:1615–1620. 339. Mansel RE. Ductal carcinoma in situ : surgery and radiotherapy. Breast 2003;12:447–450. 340. Wapnir IL, Dignam JJ, Fisher B, et al. Long-term outcomes of inva- sive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst 2011;103:478–488. 341. Morrow M, Harris JR, Schnitt SJ. Surgical margins in lumpectomy for breast cancer—bigger is not better. N Engl J Med 2012;367:79–82. 342. Hughes JH, Mason MC, Gray RJ, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J 2008;14:153–157. 343. Alderliesten T, Loo CE, Pengel KE, et al. Radioactive seed localization of breast lesions: an adequate localization method without seed migra- tion. Breast J 2011;17:594–601. 344. Thill M, Röder K, Diedrich K, et al. Intraoperative assessment of surgi- cal margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. Breast 2011;20:579–580. 345. Kinne DW, Petrek JA, Osborne MP, et al. Breast carcinoma in situ . Arch Surg 1989;124:33–36. 346. Sunshine JA, Moseley HS, Fletcher WS, et al. Breast carcinoma in situ . A retrospective review of 112 cases with minimum 10 year follow-up. Am J Surg 1985;150:44–51. 347. Carter D, Smith AL. Carcinoma in situ of the breast. Cancer 1977;40:1189–1193. 348. Boyages J, Delaney G, Taylor R. Predictors of local recurrence after treat- mentofductalcarcinoma insitu :ameta-analysis. Cancer 1999;85:616–628. 349. Clark L, Ritter E, Glazebrook K, et al. Recurrent ductal carcinoma in situ after total mastectomy. J Surg Oncol 1999;71:182–185. 350. Montgomery RC, Fowble BL, Goldstein LJ, et al. Local recurrence after mastectomy for ductal carcinoma in situ . Breast J 1998;4:430–436.

351. Finkelstein SD, Sayegh R, Thompson WR. Late recurrence of ductal carcinoma in situ at the cutaneous end of surgical drainage following total mastectomy. Am Surg 1993;59:410–414. 352. Fisher DE, Schnitt SJ, Christian R, et al. Chest wall recurrence of ductal carcinoma in situ of the breast after mastectomy. Cancer 1993;71:3025–3028. 353. Srivastava A, Webster DJT. Isolated nipple recurrence seventeen years after subcutaneous mastectomy for breast cancer—a case report. Eur J Surg Oncol 1987;13:459–461. 354. Price P, Sinnett HD, Gusterson B, et al. Duct carcinoma in situ : predic- tors of local recurrence and progression in patients treated by surgery alone. Br J Cancer 1990;61:869–872. 355. Helvie MA, Wilson TE, Roubidoux MA, et al. Mammographic ap- pearance of recurrent breast carcinoma in six patients with TRAM flap breast reconstructions. Radiology 1998;209:711–715. 356. Farrow JH. Current concepts in the detection and treatment of the earliest of the early breast cancers. Cancer 1970;25:458–479. 357. Joslyn SA. Ductal carcinoma in situ : trends in geographic, tempo- ral, and demographic patterns of care and survival. The Breast J 2006;12:20–27. 358. Kiaer W. Relation of fibroadenomatosis (“Chronic Mastitis”) to cancer of the breast . Copenhagen: Ejnar Munksgaard, 1954:69. 359. Millis RR, Thynne GSJ. In situ intraduct carcinoma of the breast: a long term follow-up study. Br J Surg 1975;62:957–962. 360. Betsill WL Jr, Rosen PP, Lieberman PH, et al. Intraductal carci- noma. Long-term follow-up after treatment by biopsy alone. JAMA 1978;239:1863–1867. 361. Rosen PP, Braun DW Jr, Kinne DW. The clinical significance of pre- invasive breast carcinoma. Cancer 1980;46:919–925. 362. Harvey DG, Fechner RE. Atypical lobular and papillary lesions of the breast: a follow-up study of 30 cases. South Med J 1978;71:361–364. 363. Page DL, Dupont WD, Rogers LW, et al. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer 1982;49:751–758. 364. Page DL, Dupont WD, Rogers LW, et al. Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy. Cancer 1995;76:1197–1200. 365. Eusebi V, Foschini MP, Cook MG, et al. Long-term follow-up of in situ carcinoma of the breast with special emphasis on clinging carci- noma. Diagn Pathol 1989;6:165–173. 366. Lagios MD, Margolin FR, Westdahl PR, et al. Mammographically de- tected duct carcinoma in situ . Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989;63:618–624. 367. Lagios MD. Evaluation of surrogate endpoint biomarkers for ductal carcinoma in situ . J Cell Biochem 1994;19(suppl.):186–188. 368. Fisher ER, Sass R, Fisher B, et al. Pathologic findings from the Na- tional Surgical Adjuvant Breast Project (Protocol 6). I. Intraductal carcinoma (DCIS). Cancer 1986;57:197–208. 369. Ottesen GL, Graversen HP, Blichert-Toft M, et al. Ductal carcinoma in situ of the female breast. Short-term results of a prospective nation- wide study. Am J Surg Pathol 1992;16:1183–1196. 370. Ringberg A, Andersson I, Aspegren K, et al. Breast carcinoma in situ in 167 women—incidence, mode of presentation, therapy and follow-up. Eur J Surg Oncol 1991;17:466–476. 371. Arnesson L-G, Smeds S, Fagerberg G, et al. Follow-up of two treat- ment modalities for ductal cancer in situ of the breast. Br J Surg 1989;76:672–675. 372. Carpenter R, Boulter PS, Cooke T, et al. Management of screen detected ductal carcinoma in situ of the female breast. Br J Surg 1989;76:564–567. 373. Schwartz GF, Finkel GC, Garcia JC, et al. Subclinical ductal carcinoma in situ of the breast. Cancer 1992;70:2468–2474. 374. Hetelekidis S, Collins L, Silver B, et al. Predictors of local recur- rence following excision alone for ductal carcinoma in situ . Cancer 1999;85:427–431. 375. Badve S, A’Hern RP, Ward AM, et al. Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological clas- sifications: a comparative study with long follow-up. Hum Pathol 1998;29:915–923. 376. Goonewardene S, Palazzo J, Cornfield D, et al. Prognostic significance of necrosis in evaluating risk for recurrence of ductal carcinoma in situ of the breast and progression to invasive carcinoma: survey of 166 conservatively treated patients. Am J Clin Pathol 1999;112: 531–532.